Exclusive interview with Pfizer CEO Albert Bourla as the company files for emergency use authorization for its COVID-19 ...

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Kathy Wylde, the head of the Partnership for New York City, lost the support of the high-powered CEOs who make up the ...

One panelist accused the F.D.A. of withholding data on potential harms. The advisers also are reviewing research on vaccines ...

It's still unclear if all patients, particularly those with insurance coverage, will see more cost savings from using that ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s ...

Bristol Myers Squibb on Thursday forecast ‌2026 ​revenue and profit above Wall Street ‌estimates, saying that price cuts to its blood thinner Eliquis will help drive up ​revenue, and shares of the U.S ...

After a brief delay last month, another piece of the Trump administration’s healthcare policy is falling into place. | On ...

The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.

Sanofi was criticized by a U.K. trade group, which accused it of making misleading claims about its RSV vaccine and ...

Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ...